ArticleJAMA network open2020

Comparative Postmarket Safety Profile of Adjuvanted and High-Dose Influenza Vaccines in Individuals 65 Years or Older.

Alexis J Pillsbury et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.